TGFB1 and neoplasm: The drug pirfenidone, for example, also exerts antitumor effects by targeting TGF‐β, as shown in renal cell carcinoma and colorectal cancer models, where it modifies the immunosuppressive TME and inhibits tumour progression [66, 67].